A carregar...
Combination therapy for metastatic renal cell carcinoma
Current therapy for metastatic clear cell renal cell carcinoma (RCC) consists of the serial administration of single agents. Combinations of VEGF and mTOR inhibitors have been disappointing in previous randomized trials. However, the combination of lenvatinib, a multitargeted agent that inhibits VEG...
Na minha lista:
| Publicado no: | Ann Transl Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4791344/ https://ncbi.nlm.nih.gov/pubmed/27047959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.01.31 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|